Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Medtech Products, Inc.

Medtech Products, Inc. Recalls

All product recalls associated with Medtech Products, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

18

Past Year

0

Class I (Serious)

0

Most Recent

Jul 2019

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–18 of 18 recalls

Clear Eyes Redness Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Assorted IRC (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Maximum Itchy Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Redness Relief Pocket Pal (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Redness Relief Pocket Pal (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Maximum Itchy Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Maximum Itchy Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Maximum Redness Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Redness Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Maximum Redness Relief Club Pack (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Assorted Sidekick (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Maximum Redness Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Redness Relief Club Pack (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Clear Eyes Redness Relief (Medtech) - Quality Control Issues (2019)

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Class IIModerate

FDAJul 26, 2019Nationwide• Medtech Products, Inc.

Little Remedies Baby Kit (Medtech) – Labeling Error (2019)

Undeclared Allergen

Incorrect/undeclared excipients: Kit carton bear incorrect labeling for two of the five items contained within the kit.

Class IIModerate

FDAMar 7, 2019Nationwide• Medtech Products, Inc.

SUCRETS Lozenges (Medtech) – Label Mix-Up (2015)

Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.

Class IIModerate

FDAMay 21, 2015Nationwide• Medtech Products, Inc.

MONISTAT 1 SIMPLE CURE (Medtech) – Unapproved Drug Marketing (2015)

Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.

FDAApr 10, 2015Nationwide• Medtech Products, Inc.

Little Remedies For Tummys (Medtech) – Subpotent Laxative (2012)

Subpotent (Single Ingredient) Drug: This product is being recalled because of sub-potency of the sennosides.

Class IIModerate

FDAJun 20, 2012Nationwide• Medtech Products, Inc.